Sihto H - Search Results

1

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T, Isola J, Heikkilä P, Joensuu H. Sihto H, et al. Breast Cancer Res. 2011 Sep 13;13(5):R87. doi: 10.1186/bcr2944. Breast Cancer Res. 2011. PMID: 21914172 Free PMC article.

2

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.

Sihto H, Sarlomo-Rikala M, Tynninen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H. Sihto H, et al. J Clin Oncol. 2005 Jan 1;23(1):49-57. doi: 10.1200/JCO.2005.02.093. Epub 2004 Nov 15. J Clin Oncol. 2005. PMID: 15545668

3

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.

Lassus H, Sihto H, Leminen A, Nordling S, Joensuu H, Nupponen NN, Butzow R. Lassus H, et al. Among authors: sihto h. Br J Cancer. 2004 Dec 13;91(12):2048-55. doi: 10.1038/sj.bjc.6602252. Br J Cancer. 2004. PMID: 15583695 Free PMC article.

4

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.

Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN. Joensuu H, et al. Among authors: sihto h. J Pathol. 2005 Oct;207(2):224-31. doi: 10.1002/path.1823. J Pathol. 2005. PMID: 16021678

5

Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors.

Sihto H, Puputti M, Pulli L, Tynninen O, Koskinen W, Aaltonen LM, Tanner M, Böhling T, Visakorpi T, Bützow R, Knuuttila A, Nupponen NN, Joensuu H. Sihto H, et al. J Mol Med (Berl). 2005 Dec;83(12):976-83. doi: 10.1007/s00109-005-0699-4. Epub 2005 Aug 31. J Mol Med (Berl). 2005. PMID: 16133419

6

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma.

Lassus H, Sihto H, Leminen A, Joensuu H, Isola J, Nupponen NN, Butzow R. Lassus H, et al. Among authors: sihto h. J Mol Med (Berl). 2006 Aug;84(8):671-81. doi: 10.1007/s00109-006-0054-4. Epub 2006 Apr 11. J Mol Med (Berl). 2006. PMID: 16607561

7

Allelic imbalance of HER2 variant in sporadic breast and ovarian cancer.

Puputti M, Sihto H, Isola J, Butzow R, Joensuu H, Nupponen NN. Puputti M, et al. Among authors: sihto h. Cancer Genet Cytogenet. 2006 May;167(1):32-8. doi: 10.1016/j.cancergencyto.2004.09.023. Cancer Genet Cytogenet. 2006. PMID: 16682283

8

Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.

Sihto H, Franssila K, Tanner M, Vasama-Nolvi C, Sarlomo-Rikala M, Nupponen NN, Joensuu H, Isola J. Sihto H, et al. Scand J Gastroenterol. 2006 Jul;41(7):805-11. doi: 10.1080/00365520500483207. Scand J Gastroenterol. 2006. PMID: 16785193

9

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

Puputti M, Tynninen O, Sihto H, Blom T, Mäenpää H, Isola J, Paetau A, Joensuu H, Nupponen NN. Puputti M, et al. Among authors: sihto h. Mol Cancer Res. 2006 Dec;4(12):927-34. doi: 10.1158/1541-7786.MCR-06-0085. Mol Cancer Res. 2006. PMID: 17189383 Free article.

10

Endothelial cell KIT expression in human tumours.

Sihto H, Tynninen O, Bützow R, Saarialho-Kere U, Joensuu H. Sihto H, et al. J Pathol. 2007 Mar;211(4):481-8. doi: 10.1002/path.2125. J Pathol. 2007. PMID: 17294421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters